All Issue

2021 Vol.2, Issue 2 Preview Page

Review article

June 2021. pp. 57-62
Abstract
Sorry, not available.
Click the PDF button.
References
1
Solakhan M et al., Efficacy of mirabegron in medical expulsive therapy, Urolithiasis, 2019 10.1007/s00240-018-1075-5
2
Aboumarzouk OM et al., What Is the Role of alpha-Blockers for Medical Expulsive Therapy? Results From a Meta-analysis of 60 Randomized Trials and Over 9500 Patients, Urology, 2018 10.1016/j.urology.2018.03.028
3
De Coninck V et al., Medical Expulsive Therapy for Urinary Stones: Future Trends and Knowledge Gaps, Eur Urol, 2019 10.1016/j.eururo.2019.07.053
4
Abou Chakra M et al., Established and recent developments in the pharmacological management of urolithiasis: an overview of the current treatment armamentarium, Expert Opin Pharmacother, 2020
5
Campschroer T et al., Alpha-blockers as medical expulsive therapy for ureteral stones, Cochrane Database Syst Rev, 2014 10.1002/14651858.CD008509.pub2
6
Yilmaz E et al., The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones, J Urol, 2005 10.1097/01.ju.0000158453.60029.0a
7
Sun X et al., Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones, J Urol, 2009 10.1016/j.juro.2008.11.118
8
Liu XJ et al., Role of silodosin as medical expulsive therapy in ureteral calculi: a meta-analysis of randomized controlled trials, Urolithiasis, 2018 10.1007/s00240-017-0974-1
9
Pickard R et al., Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial, Lancet, 2015 10.1016/S0140-6736(15)60933-3
10
Hermanns T et al., Is there a role for tamsulosin in the treatment of distal ureteral stones of 7 mm or less? Results of a randomised, double-blind, placebo-controlled trial, Eur Urol, 2009 10.1016/j.eururo.2009.03.076
11
Meltzer AC et al., Effect of Tamsulosin on Passage of Symptomatic Ureteral Stones: A Randomized Clinical Trial, JAMA Intern Med, 2018 10.1001/jamainternmed.2018.2259
12
Vincendeau S et al., Tamsulosin hydrochloride vs placebo for management of distal ureteral stones: a multicentric, randomized, double-blind trial, Arch Intern Med, 2010 10.1001/archinternmed.2010.447
13
Furyk JS et al., Distal Ureteric Stones and Tamsulosin: A Double-Blind, Placebo-Controlled, Randomized, Multicenter Trial, Ann Emerg Med, 2016 10.1016/j.annemergmed.2015.06.001
14
Sur RL et al., Silodosin to facilitate passage of ureteral stones: a multi-institutional, randomized, double-blinded, placebo-controlled trial, Eur Urol, 2015 10.1016/j.eururo.2014.10.049
15
Seitz C et al., Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol, 2009 10.1016/j.eururo.2009.06.012
16
Cao D et al., A comparison of nifedipine and tamsulosin as medical expulsive therapy for the management of lower ureteral stones without ESWL, Sci Rep, 2014 10.1038/srep05254
17
Porpiglia F et al., Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones: single drug or association? Eur Urol, 2006 10.1016/j.eururo.2006.02.023
18
Saita A et al., Our experience with nifedipine and prednisolone as expulsive therapy for ureteral stones, Urol Int, 2004 10.1159/000076591
19
Montes Cardona CE et al., Efficacy of phosphodiesterase type 5 inhibitors for the treatment of distal ureteral calculi: A systematic review and meta-analysis, Investig Clin Urol, 2017 10.4111/icu.2017.58.2.82
20
Turk C et al., EAU guidelines on urolithiasis, 2019
21
Assimos D et al., Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I, J Urol, 2016 10.1016/j.juro.2016.05.09127238615
22
Ordon M et al., CUA Guideline: Management of ureteral calculi, Can Urol Assoc J, 2015 10.5489/cuaj.3483
23
NICE Guideline, Renal and ureteric stones: assessment and management: NICE (2019) Renal and ureteric stones: assessment and management, BJU Int, 2019
24
Trinchieri A et al., Prevalence of renal uric acid stones in the adult, Urolithiasis, 2017 10.1007/s00240-017-0962-5
25
Trinchieri A et al., Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/ potassium bicarbonate, Arch Ital Urol Androl, 2009
26
Tsaturyan A et al., Oral chemolysis is an effective, non-invasive therapy for urinary stones suspected of uric acid content, Urolithiasis, 2020 10.1007/s00240-020-01204-8
27
Elbaset MA et al., Optimal non-invasive treatment of 1-2.5 cm radiolucent renal stones: oral dissolution therapy, shock wave lithotripsy or combined treatment-a randomized controlled trial, World J Urol, 2020 10.1007/s00345-019-02746-2
28
Gridley CM et al., Medical dissolution therapy for the treatment of uric acid nephrolithiasis, World J Urol, 2019 10.1007/s00345-019-02688-9
29
Moran ME et al., Utility of oral dissolution therapy in the management of referred patients with secondarily treated uric acid stones, Urology, 2002 10.1016/S0090-4295(01)01499-6
30
Elsawy AA et al., Can we predict the outcome of oral dissolution therapy for radiolucent renal calculi? a prospective study, J Urol, 2019 10.1016/j.juro.2018.09.027
31
Shekarriz B et al., Uric acid nephrolithiasis: current concepts and controversies, J Urol, 2002 10.1097/00005392-200210010-00003
32
Kim JC et al., Predictors of uric acid stones: mean stone density, stone heterogeneity index, and variation coefficient of stone density by single-energy non-contrast computed tomography and urinary pH, J Clin Med, 2019 10.3390/jcm8020243
Information
  • Publisher :The Association of Korean Urologists
  • Publisher(Ko) :대한비뇨의학과의사회
  • Journal Title :비뇨의학 Urology Digest
  • Volume : 2
  • No :2
  • Pages :57-62